-
-
(1R,4R)-2,5-Di
phenylbicyclo[2.2.2]octa-2,5-diene,98%, 250mg
-
(1R,4R)-2,5-Di
phenylbicyclo[2.2.2]octa-2,5-diene,98%, 100mg
-
(11AR)-(+)-10,11,12,13-tetrahydrodiindeno[7,1-de:1’,7′-fg][1,3,2]dioxaphosphocin-5-phenoxy,98%, 100mg
-
(R)-Phanephos,98%, 50mg
-
N-[(1S)-2′-aMino[1,1′-binaphthalen]-2-yl]-AcetaMide,98%, 5g
-
1S,2S-N-[3,5-bis(trifluoromethyl)]benzenesulfonamide-1,2-di
phenyl ethylenediamine,97%, 1g
-
1S,2S-N-[3,5-bis(trifluoromethyl)]benzenesulfonamide-1,2-di
phenyl ethylenediamine,97%, 100mg
-
1S,2S-N-[3,5-bis(trifluoromethyl)]benzenesulfonamide-1,2-di
phenyl ethylenediamine,97%, 250mg
-
(4S,4’S)-2,2′-(Cyclohexane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole),97%, 250mg
-
(4S,4’S)-2,2′-(Cyclohexane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole),97%, 1g
-
(4S,4’S)-2,2′-(Cyclohexane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole),97%, 100mg
стр.: